These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

67 related items for PubMed ID: 2686075

  • 1. [Interferon in the treatment of acute viral hepatitis B].
    Gorbarets IP, Ketiladze ES, Farber NA, Bugaeva NP, Nemtsova EV.
    Ter Arkh; 1989; 61(8):69-71. PubMed ID: 2686075
    [Abstract] [Full Text] [Related]

  • 2. [An assessment of the therapeutic efficacy of gene-engineered human alpha 2-interferon in patients with acute viral hepatitis B].
    Pokrovskiĭ VI, Zmyzgova AV, Botsvadze ESh, Andreĭchin MA, Frolov VM, Murzabaeva RT, Mesniankin AP, Kokareva LN, Malinovskaia VV.
    Ter Arkh; 1990; 62(2):139-43. PubMed ID: 2186494
    [Abstract] [Full Text] [Related]

  • 3. [Reaferon treatment in acute HBsAG-positive viral hepatitis].
    Gorbarets IP, Ketiladze ES, Farber NA, Bugaeva NP, Braginskiĭ DM.
    Klin Med (Mosk); 1990 Mar; 68(3):65-8. PubMed ID: 2370758
    [Abstract] [Full Text] [Related]

  • 4. [Effect of interferon on clinico-laboratory indicators in patients with acute viral hepatitis B].
    Pokrovskiĭ VI, Zmyzgova AV, Matveeva SM, Saltykov VP, Soibnazarov ISh.
    Ter Arkh; 1986 Mar; 58(10):29-32. PubMed ID: 3798344
    [Abstract] [Full Text] [Related]

  • 5. Recombinant alpha-interferon may be efficacious in acute hepatitis B.
    Halevy J, Achiron A, Spiegel D, Nili M, Luboshits J, Yerushalmi Y, Theodor E.
    Am J Gastroenterol; 1990 Feb; 85(2):210-2. PubMed ID: 2301343
    [Abstract] [Full Text] [Related]

  • 6. [The treatment of different forms of B and delta hepatitis with interferon preparations].
    Botsvadze ESh, Kuznetsov VP, Aleksishvili MM, Gogichaĭshvili ShSh.
    Ter Arkh; 1991 Feb; 63(11):61-3. PubMed ID: 1810067
    [Abstract] [Full Text] [Related]

  • 7. Pretransplantation interferon treatment and recurrence of hepatitis B virus infection after liver transplantation for hepatitis B-related end-stage liver disease.
    Marcellin P, Samuel D, Areias J, Loriot MA, Arulnaden JL, Gigou M, David MF, Bismuth A, Reynes M, Bréchot C.
    Hepatology; 1994 Jan; 19(1):6-12. PubMed ID: 8276368
    [Abstract] [Full Text] [Related]

  • 8. [The efficacy of recombinant alfa-2 interferon in viral hepatitis B].
    Frolov AF, Vovk AD, Diadiun ST, Antonenko SV, Petrovskaia IA, Fedorchenko SV, Kushko LIa, Antoniak SN.
    Vrach Delo; 1990 Sep; (9):105-8. PubMed ID: 1704663
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Renal allograft function in patients with chronic viral hepatitis B and C treated with interferon alpha.
    Durlik M, Gaciong Z, Rancewicz Z, Rowińska D, Wyzgał J, Kozłowska B, Gradowska L, Lao M, Nowaczyk M, Korczak-Kowalska G.
    Transplant Proc; 1995 Feb; 27(1):958-9. PubMed ID: 7879245
    [No Abstract] [Full Text] [Related]

  • 11. Treatment of chronic viral hepatitis type B with oral mucosal administration of natural human interferon alpha lozenges.
    Caban J, Mossor-Ostrowska J, Zyrkowska-Bieda T, Zejc M, Janas-Skulina U, Cieśla A, Cummins JM, Georgiades JA.
    Arch Immunol Ther Exp (Warsz); 1993 Feb; 41(3-4):229-35. PubMed ID: 8129566
    [Abstract] [Full Text] [Related]

  • 12. [Therapy of chronic hepatitis B with interferon].
    Vogel W.
    Wien Med Wochenschr; 1993 Feb; 143(16-17):458-60. PubMed ID: 8273372
    [Abstract] [Full Text] [Related]

  • 13. [Leukinferon in the treatment of patients with acute viral hepatitis b].
    Golban TD, Cheshin SG, Kuznetsov VP, Farber NA, Beliaev DL, Kirzhner LS, Babaiants AA, Vasina VI.
    Klin Med (Mosk); 1994 Feb; 72(3):27-9. PubMed ID: 7990347
    [Abstract] [Full Text] [Related]

  • 14. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
    Musch E, Högemann B, Gerritzen A, Fischer HP, Wiese M, Kruis W, Malek M, Gugler R, Schmidt G, Huchzermeyer H, Gerlach U, Dengler HJ, Sauerbruch T.
    Hepatogastroenterology; 1998 Feb; 45(24):2282-94. PubMed ID: 9951911
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Interferon treatment in children with chronic hepatitis B.
    Ruíz-Moreno M.
    J Hepatol; 1995 Feb; 22(1 Suppl):49-51. PubMed ID: 7602077
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the long-term effects of treatment with oral and parenteral interferon alpha in chronic viral hepatitis patients.
    Zielińska W, Korczak-Rogoń A, Paszkiewicz J, Kowalik M, Cummins JM, Georgiades JA.
    Arch Immunol Ther Exp (Warsz); 1996 Feb; 44(5-6):359-66. PubMed ID: 9017152
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Treatment of fourteen chronic active HBsAg+, HBeAg+ hepatitis patients with low dose natural human interferon alpha administered orally.
    Zielińska W, Paszkiewicz J, Korczak A, Własiuk M, Zółtowska A, Szutowicz A, Cummins JM, Georgiades JA.
    Arch Immunol Ther Exp (Warsz); 1993 Feb; 41(3-4):241-51. PubMed ID: 8129568
    [Abstract] [Full Text] [Related]

  • 20. [Immediate hypersensitivity reaction in acute viral hepatitis A and B treated with interferon inducers].
    Andreĭchin MA, Rudchik AS, Borak VF.
    Sov Med; 1989 Feb; (11):10-4. PubMed ID: 2626696
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.